Efficacy and Safety of High-Dose IFN-?2b in Patients With High-Risk Resected Cutaneous Melanoma

John M. Kirkwood, MD

Professor and Vice Chair

Department of Medicine

University of Pittsburgh Cancer Institute

Chairman, ECOG Melanoma Committee

C

Next slide

Back to first slide

View graphic version